![Marek Dobke](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marek Dobke
Corporate Officer/Principal at UC San Diego School of Medicine
Network origin in Marek Dobke first degree
Entity | Entity type | Industry | |
---|---|---|---|
UC San Diego School of Medicine
4
| College/University | Other Consumer Services | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Marek Dobke via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
University of California, Riverside | College/University | Undergraduate Degree | |
Embic Corp.
![]() Embic Corp. Information Technology ServicesTechnology Services Medical Care Corp. specializes in developing technologies for the precise measurement and monitoring of cognitive performance. The company was founded by William R. Shankle and Junko Hara in 1999 and is headquartered in Newport Beach, CA. | Information Technology Services | Corporate Officer/Principal | |
Tau Ventures LLC
![]() Tau Ventures LLC Investment ManagersFinance Tau Ventures LLC (Tau Ventures) is a venture capital firm founded in 2018 by Amit Garg and Sanjay K. Rao. The firm is headquartered in Palo Alto, California. | Investment Managers | Consultant / Advisor | |
The Docs, Inc.
![]() The Docs, Inc. The Docs, Inc. plans to provide a clinic that keeps diabetes prevention and treatment in mind while integrating proactive screenings of the associated co-morbidities. The company was founded by Mark A. Cole on April 16, 2017 and is headquartered in Las Vegas, NV. | Chief Tech/Sci/R&D Officer | ||
Oxitope Pharma BV
![]() Oxitope Pharma BV Pharmaceuticals: MajorHealth Technology Oxitope Pharma BV is a Dutch pharmaceutical start-up founded in 2020 that focuses on discovering and developing medicine for the treatment of inflammatory and cardiovascular diseases caused by oxidative stress. The company is based in Naarden, Netherlands. The Dutch company takes a different approach to the diagnosis and treatment of these diseases by preventing, halting, or reversing acute and chronic diseases driven by oxidized phospholipids. Oxitope Pharma's goal is to enable people to live long and healthy lives. The CEO is John Montana. | Pharmaceuticals: Major | Director/Board Member | |
St. Georges University School of Medicine
![]() St. Georges University School of Medicine Other Consumer ServicesConsumer Services St. Georges University School of Medicine. The company is headquartered in Grenada. | College/University | Graduate Degree |
Statistics
International
United States | 5 |
Netherlands | 2 |
Sectoral
Consumer Services | 3 |
Technology Services | 2 |
Finance | 2 |
Health Technology | 2 |
Operational
Corporate Officer/Principal | 5 |
Director/Board Member | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Most connected contacts
Insiders | |
---|---|
Asheesh K. Dewan | 5 |
Sotirios Tsimikas | 2 |
Michael Rafii | 2 |
Ralph Greenspan | 1 |
- Stock Market
- Insiders
- Marek Dobke
- Company connections